| J Michael Gruenwald, MD FACS | |
|
515 Read St, Evansville, IN 47710-1739 | |
| (812) 424-9291 | |
| Not Available |
| Full Name | J Michael Gruenwald |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 47 Years |
| Location | 515 Read St, Evansville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275623761 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arctic Medical Center | 1557798634 | 7 |
News Archive
Biophotonics, or photomedicine, is a relatively unknown discipline, though it has existed for years now. You may have even benefited from it without realizing it. Some of the greatest advances of this field can be found in applications for the areas of oncology, dermatology, ophthalmology, surgery and cardiology.
Hundreds of home care and hospice providers will arrive in that nation's capitol to keep the fight alive for the critical, high-value, high-quality care that is delivered every day to some of the nation's most vulnerable individuals.
A new study suggests that pilots who fly at high altitudes may be at an increased risk for brain lesions. The study is published in the August 20, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.
Prostate cancer is the most common non-skin cancer in American men and the third most common cause of cancer death. In patients with localized disease, radical prostatectomy is associated with lower disease-specific mortality, lower rates of local progression and metastases, and higher overall survival compared with conservative management.
Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced top-line results from a successful Phase 2b double-blind, randomized, placebo-controlled clinical trial of its lead topical pain candidate, ARC-4558, in adult patients with painful diabetic neuropathy (PDN). Arcion recently held an End of Phase 2 meeting with the United States Food and Drug Administration (FDA) and the ARC-4558 program is now poised to enter Phase 3 studies.
› Verified 8 days ago
| Entity Name | Arctic Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962040006 PECOS PAC ID: 1557798634 Enrollment ID: O20200302002012 |
News Archive
Biophotonics, or photomedicine, is a relatively unknown discipline, though it has existed for years now. You may have even benefited from it without realizing it. Some of the greatest advances of this field can be found in applications for the areas of oncology, dermatology, ophthalmology, surgery and cardiology.
Hundreds of home care and hospice providers will arrive in that nation's capitol to keep the fight alive for the critical, high-value, high-quality care that is delivered every day to some of the nation's most vulnerable individuals.
A new study suggests that pilots who fly at high altitudes may be at an increased risk for brain lesions. The study is published in the August 20, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.
Prostate cancer is the most common non-skin cancer in American men and the third most common cause of cancer death. In patients with localized disease, radical prostatectomy is associated with lower disease-specific mortality, lower rates of local progression and metastases, and higher overall survival compared with conservative management.
Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced top-line results from a successful Phase 2b double-blind, randomized, placebo-controlled clinical trial of its lead topical pain candidate, ARC-4558, in adult patients with painful diabetic neuropathy (PDN). Arcion recently held an End of Phase 2 meeting with the United States Food and Drug Administration (FDA) and the ARC-4558 program is now poised to enter Phase 3 studies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| J Michael Gruenwald, MD FACS 515 Read St, Evansville, IN 47710-1739 Ph: (812) 424-9291 | J Michael Gruenwald, MD FACS 515 Read St, Evansville, IN 47710-1739 Ph: (812) 424-9291 |
News Archive
Biophotonics, or photomedicine, is a relatively unknown discipline, though it has existed for years now. You may have even benefited from it without realizing it. Some of the greatest advances of this field can be found in applications for the areas of oncology, dermatology, ophthalmology, surgery and cardiology.
Hundreds of home care and hospice providers will arrive in that nation's capitol to keep the fight alive for the critical, high-value, high-quality care that is delivered every day to some of the nation's most vulnerable individuals.
A new study suggests that pilots who fly at high altitudes may be at an increased risk for brain lesions. The study is published in the August 20, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.
Prostate cancer is the most common non-skin cancer in American men and the third most common cause of cancer death. In patients with localized disease, radical prostatectomy is associated with lower disease-specific mortality, lower rates of local progression and metastases, and higher overall survival compared with conservative management.
Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced top-line results from a successful Phase 2b double-blind, randomized, placebo-controlled clinical trial of its lead topical pain candidate, ARC-4558, in adult patients with painful diabetic neuropathy (PDN). Arcion recently held an End of Phase 2 meeting with the United States Food and Drug Administration (FDA) and the ARC-4558 program is now poised to enter Phase 3 studies.
› Verified 8 days ago
James Arthur Rang, M.D. M.B.A. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 515 Read St, Evansville, IN 47710 Phone: 812-424-9291 Fax: 812-421-2722 | |
James M. Heinrich, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 225 Cross Lake Dr., Evansville, IN 47715 Phone: 812-477-1558 | |
Andrew T. Saltzman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 225 Crosslake Dr, Evansville, IN 47715 Phone: 812-477-1558 | |
Phillip L. Stiver, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 225 Crosslake Dr, Evansville, IN 47715 Phone: 812-477-1558 | |
John P. Morgan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1150 Lincoln Ave, Evansville, IN 47714 Phone: 812-402-4263 Fax: 812-437-4263 | |
Jacob M O'neill, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 225 Crosslake Dr, Evansville, IN 47715 Phone: 812-477-1558 Fax: 812-488-4669 | |
Paul Deming Alley, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1150 Lincoln Ave, Evansville, IN 47714 Phone: 812-402-4263 Fax: 812-437-4263 |